| Product |
Cat# |
IFU |
Incubation |
Stand.Range/Sensitivity |
Specimen |
Type |
Method |
Units |
| Vitamin Niacin |
BIO4882 |
IFU |
48 h at 37 C |
4 - 40 mg/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
| Vitamin B12 |
BIO4883 |
IFU |
48 h at 37 C |
6 - 54 ng/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
| Vitamin Biotin |
BIO4884 |
IFU |
48 h at 37 C |
0.02 - 0.18 ug/L /// --- |
50 ul serum |
quantitative |
MTPL |
96 wells |
| Vitamin B6 (Pyridoxin) |
BIO4885 |
IFU |
48 h at 37 C |
0.36 - 3 ug/L /// --- |
300 ul serum |
quantitative |
MTPL |
96 wells |
| Vitamin Folic Acid |
BIO4886 |
IFU |
48 H at 37 C |
0.04 - 0.32 ug/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
| Vitamin B2 (Riboflavin) |
BIO4887 |
IFU |
48 h at 37 C |
5 - 60 ng/L /// --- |
150 ul serum |
quantitative |
MTPL |
96 wells |
| Vitamin B1 (Thiamin) (old number BIO4880) |
BIO5136 |
IFU |
24 h at 37 C |
3 - 15 ng/L /// - |
100 ul whole blood |
quantitative |
MTPL |
96 tests |
| Vitamin Pantothenic Acid Bio-Assay |
BIO5264 |
|
24 h at 37C |
2.3 - 36.8 ug/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
| Lumi Stat (sensitive Luminometer for micro well strips) |
CLA4648 |
|
|
|
|
|
|
each |
| Diol, 3 alpha diol G (5aAndrostone 3a17Bdiol Glucuronide) |
CLA4649 |
IFU |
15 /15 min |
0.25 - 50 ng/ml // 0.1 ng/ml |
5 ul serum |
quantitative |
MTPL |
96 wells |
| Aldosterone |
CLA4650 |
IFU |
60 / 10 min |
20 - 2000 pg/m // 10 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| Cortisol |
CLA4651 |
IFU |
30 / 10 - 15 min |
0.5 - 60 ug/dL /// 0.15 ug/dl |
20 ul serum |
quantitative |
MTPL |
96 wells |
| DHEA-S |
CLA4652 |
IFU |
30 / 10 - 15 min |
0.02 - 10 ug/dL /// 0.02 ug/dl |
25 ul serum |
quantitative |
MTPL |
96 wells |
| Estriol Saliva |
CLA4653 |
IFU |
45 / 20 / 10 - 15 min |
0.1 - 100 pg/ml /// 0.7 pg/ml |
50 ul saliva |
quantitative |
MTPL |
96 wells |
| Estrone Serum |
CLA4654 |
IFU |
30 / 10 - 15 min |
15 - 2000 pg/ml /// 8.8 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| Estrone Saliva |
CLA4655 |
IFU |
60 / 30 / 10 - 15 min |
2 - 800 pg/ml // 1.0 pg/ml |
100 ul saliva |
quantitative |
MTPL |
96 wells |
| Progesterone |
CLA4656 |
IFU |
60 / 10 min |
0.1 - 60 ng/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
| PSA, Total (Prostate Specific Antigen) |
CLA4657 |
IFU |
30 / 30 / 10 - 15 min. |
0.005 - 100 ng/ml /// 0.002 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| TSH |
CLA4658 |
IFU |
30 / 10 - 15 min |
0.008 - 25 ulU/ml // 0.002 ulU/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| T-4, free |
CLA4659 |
IFU |
30 min 27 C / 10/15 min RT |
2 - 120 pg/ml /// 1 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
| Testosterone, free |
CLA4660 |
IFU |
30 min 37 C / 10 - 15 min |
0.25 - 100 pg/ml /// 0.17 pg/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
| Testosterone, Saliva |
CLA4661 |
IFU |
30 / 30 / 10 - 15 min |
2 - 800 pg/ml /// 1.0 pg/ml |
100 ul saliva |
quantitative |
MTPL |
96 wells |
| Testosterone (serum) CLA |
CLA4662 |
IFU |
min |
|
serum |
quantitative |
MTPL |
96 wells |
| Progesterone (serum) CLA |
CLA4663 |
IFU |
min |
|
serum |
quantitative |
MTPL |
96 wells |
| Estradiol (serum) CLA |
CLA4664 |
IFU |
min |
|
serum |
quantitative |
MTPL |
96 wells |
| Progesterone / 17a Hydroxy-Progesterone (serum) CLA |
CLA4665 |
IFU |
min |
|
serum |
quantitative |
MTPL |
96 wells |
| Cortisol (serum) CLA |
CLA4666 |
IFU |
30 / 10 min |
20-800 ng/ml /// 0.48 ng/ml |
20 ul serum |
quantitative |
MTPL |
96 wells |
| DHEA-S (serum) CLA |
CLA4667 |
IFU |
min. |
|
serum |
quantitative |
MTPL |
96 wells |
| Prolactin |
CLA4729 |
IFU |
30 min |
5-200 ng/ml /// 0.3 ng/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
| TM-CA 72-4 |
CLA4730 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| TM-CYRFRA 21-1 |
CLA4731 |
IFU |
30 min. |
3 - 50 ng/ml /// 0.03 ng/ml |
50 ul serum, heparin plasma |
qualitative |
MTPL |
96 wells |
| CMV IgM CLA |
CLA5196 |
|
30min 37C / 30 / 15 min. RT |
3 standards |
10 ul serum |
quantitative |
MTPL |
96 wells |
| Rubella IgM CLA |
CLA5197 |
|
30min 37C / 30 / 15 min. RT |
3 Standards |
10 ul serum |
quantitative |
MTPLL |
96 wells |
| Toxoplasma gondii IgM |
CLA5198 |
|
30min 37C/ 30 / 15 min RT |
3 standards |
10 uL serum |
quantitative |
MTPL |
96 wells |
| HSV 1 IgM CLA |
CLA5199 |
|
30min 37C/ 30/15 min. RT |
|
10 uL serum |
qualitative |
MTPL |
96 wells |
| HSV 2 IgM CLA |
CLA5200 |
|
30min 37C / 30/15min. RT |
|
10 uL serum |
qualitative |
MTPL |
96 Wells |
| Amyloid beta 1-40 (colometric) |
COL3994 |
IFU |
6.5 h |
|
|
quantitative |
COLO |
96 tests |
| Amyloid beta 1-42 (colometric) |
COL3995 |
IFU |
6.5 h |
|
|
quantitative |
COLO |
96 tests |
| Tumor Marker Control II (1 vial, o.5 ml lyophilized) |
CTL4755 |
|
|
|
|
|
|
1 vial |
| Tumor Marker Control I (1 vial, 0.5 ml lyophilized) |
CTL4756 |
|
|
|
|
controls |
|
1 vial |
| Diabetes-antigen Control (rat, mouse) (3 vials /ea.0.5ml) |
CTL4783 |
IFU |
|
|
|
controls |
|
3 vials /0.5 ml |
| Animal Insulin Control (3 vials /ea.0.5ml) |
CTL4784 |
IFU |
|
|
|
controls |
|
1 vial |
| Drugs of Abuse Control negative, Level 1 (6 x 18 mL) |
CTL5076 |
|
|
|
|
controls |
|
6x18mL |
| Drugs of Abuse Control low challenge to immunoassay cutoff, Level 2 |
CTL5077 |
|
|
|
|
controls |
|
6x18mL |
| Drugs of Abuse Control High challenge to immunoassay cutoff, level 3 |
CTL5078 |
|
|
|
|
controls |
|
6x18mL |
| Drugs of Abuse Control elevated immunoassay, level 4 |
CTL5079 |
|
|
|
|
controls |
|
6x18mL |
| Diabetes Control Set (human Insulin) Low + High (unit 2 x 0.5 ml) |
CTL5132 |
IFU |
|
|
|
controls |
|
2 x 0.5ml |
| Rat Control (Fertility / Pregnancy) |
CTL5262 |
IFU |
|
|
|
controls |
|
2 x 1 ml |
| HepAK Dot |
DOT4274 |
|
30/30/10-12 min. RT (+30 min d |
no qualitative evaluat. (compare with pos Dot control) // up to |
10 ul serum, plasma |
pos. dot control |
bot strips |
96 (24x4) tests |
| HepAK plus Dot |
DOT4275 |
|
30/30/10-12 min. RT (+30 min. |
no qualit. evaluation (compare w. pos. Dot control) // up to 91 |
10 ul serum, plasma |
pos. dot control |
blot strip |
120 (24x5) tests |